Status:
ACTIVE_NOT_RECRUITING
Neonatal Brain Oxygenation Study
Lead Sponsor:
Stanford University
Conditions:
Cerebral Hypoxia
Eligibility:
All Genders
Up to 2 years
Phase:
NA
Brief Summary
Implementing target ranges for regional cerebral saturations in extremely preterm infants in the first week of life may improve neurodevelopmental outcomes at 22-26 months corrected age compared to th...
Eligibility Criteria
Inclusion
- Very preterm infants with gestational age at least 23 weeks but less than 29 completed weeks
- Less than 6 hours of age
Exclusion
- Skin integrity insufficient to allow placement of NIRS sensors
- Decision not to provide full intensive care support
- Congenital condition, other than premature birth, that adversely affects life expectancy or neurodevelopment
Key Trial Info
Start Date :
August 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04439968
Start Date
August 10 2021
End Date
December 31 2025
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lucile Packard Children's Hospital Stanford
Palo Alto, California, United States, 94304